AlphAIalphai — Financial news for AI agents
marketscreener.comAUG 201 min read

Medtronic to Pay Quarterly Dividend of $0.72 a Share, Payable Oct. 16 to Holders of Record Sept. 25

Medtronic announced a quarterly dividend of $0.72 per share, payable on October 16 to shareholders of record on September 25. The company's stock has seen a 5-day change of -1.94% and a year-to-date change of +1.90%.

Original reporting
marketscreener.com
Published Aug 20, 2026, 9:01 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 21, 2026, 10:40 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
alphai market briefCorporate actions
Primary signal
MARKET
Neutral
AI market analysis
Mentioned
$MDT
Relevance
5/10
alphai data visualization · based on marketscreener.com
Decision brief

The 30-second read

Med
01

Why it matters

The dividend announcement provides a clear, time‑bound catalyst for short‑term trading strategies.

02

Market read

A routine corporate action that may generate modest trading activity around the ex‑dividend date.

03

What to watch

Potential tax considerations for dividend‑receiving investors and upcoming earnings guidance.

Relevance 5/10Novelty 6/10Timing: payable Oct. 16, record date Sept. 25

Background

Medtronic (MDTC) is a leading medical device manufacturer listed on the NYSE.

Market effects

Sector

May boost sentiment in the medical devices sector as dividend‑paying peers are viewed favorably.

Regional

Limited to U.S. investors; no broader regional effect.

Global

Minimal global impact beyond Medtronic shareholders.

Counterpoint

What could challenge this read

Dividend could signal limited growth opportunities, prompting some investors to favor higher‑growth peers.

Key entities

  • Company
    Medtronic

    Medical device manufacturer announcing dividend.

Read at source← All news

Related articles

AUG 23
$DHRMedAI 8/10

Danaher vs. Medtronic: Which Healthcare Recovery Story Has More Upside?

Danaher (DHR) and Medtronic (MDT) report recovery signs. DHR benefits from life sciences demand, with bioprocessing orders growing mid-teens. MDT shows highest annual revenue growth in 10 years, with Q4 revenue at $9.8B and FY26 at $36.4B. MDT's cardiac segment grew 78% globally, driven by cardiac ablation solutions. Both companies face challenges, with MDT's growth concentrated in a few platforms and DHR's revenue delayed into next year.

yahoo.com3 min
AUG 23
$MDTMedAI 8/10

Medtronic vs. Tenet Healthcare: Which Healthcare Stock Offers Better Long-Term Growth?

Medtronic (MDT) and Tenet Healthcare (THC) present distinct growth prospects. MDT reported its highest annual revenue growth in a decade, driven by cardiac ablation solutions and investments in innovation. THC saw a 52.2% increase in adjusted EPS and 6.8% revenue growth, with margin expansion in hospitals. Investors must choose between MDT's innovation-led recovery and THC's operational improvements.

yahoo.com3 min
AUG 19
$ISRGMed

Johnson & Johnson and Medtronic Enter the Fray, Squeezing Market Share as Intuitive Surgical Faces Its Biggest Challenge in Recent Years

Intuitive Surgical (ISRG) stock fell 30% in 2026 due to weak guidance, competition, and high valuations. Q2 revenue grew 19%, but full-year procedure growth guidance was below expectations. Competitors like Johnson & Johnson and Medtronic are entering the market, raising concerns about ISRG's market share. Analysts note high valuation multiples and slowing growth may pressure the stock further.

nai500.com2 min